Cit Leads $135.6 Million Financing For Superior Biologics
12/01/22, 2:07 PM
Location
pennsylvania
Money raised
$136 million
Industry
biotechnology
health care
CIT, a division of First Citizens Bank, today announced that its Healthcare Finance business served as lead arranger of $135.6 million in financing for Superior Biologics Inc.
Company Info
Location
pennsylvania, united states
Additional Info
Superior Biologics is a leading, independent specialty pharmacy that provides specialty drugs and home infusion therapy services. Our company offers a high-touch, patient-centric model, utilizing an affiliated network of 130+ nurses to provide highly personal care to patients. We provide advanced clinical pharmacy and nursing services across multiple therapeutic areas, including: immunology, hematology, neurology, oncology, and rheumatology. Our key focus is on immunoglobulin therapy (IVIG) for patients with immuno-deficiency and autoimmune disorders, and blood-clotting factor for patients with bleeding disorders (hemophilia).
Our Mission:
To inspire healthier communities by blending passionate professionals, innovative technology and unsurpassed clinical care.